National Institutes of Health (NIH) — Full Portfolio
2,626 tracked investments · page 1 of 14 · listed companies and verified rows first
Achieve Life Sciences is a late-stage specialty pharmaceutical company developing cytisinicline, a treatment for nicotine dependence and smoking cessation.
BiotechHealthtechVancouver, B.C., US
Anthony Clarke(Executive Officer)Richard Stewart(Director)Cindy Jacobs(Executive Officer, Director)inJaime Xinos(Executive Officer)inJohn Bencich(Executive Officer, Director)in
BoardBridget Martell(Director)
Co-investorsvenBio PartnersVivo CapitalFrazier Life Sciences
BiotechSan Diego, US
Richard H. Tullis(Executive Officer, Director)James B. Frakes(Executive Officer, Director)Rodney S. Kenley(Executive Officer, Director)James Joyce(Executive Officer, Director)inRICHARD H. TULLIS, PhD(Executive Officer)
BoardChetan S. Shah, M.D.(Director)
Agenus develops immunotherapies for cancer treatment, building a portfolio of antibody therapeutics, adoptive cell therapies, and adjuvant and vaccine platforms that work across the cancer immunity cycle.
BiotechHealthtechLexington, US
Garo Armen(Executive Officer, Director)Ozer Baysal(Executive Officer)Robert Stein(Executive Officer)Christine Klaskin(Executive Officer)Karen Valentine(Executive Officer)
BoardBrian Corvese(Director)
Co-investorsAdvent Life SciencesGrazia Equity GmbHHEALTHCARE ROYALTY PARTNERSOberland CapitalCommodore CapitalInvus+2 more
Alto Neuroscience is a clinical-stage biopharmaceutical company developing biology-driven medicines for neuropsychiatric conditions, using measurements of brain biology to predict clinical response and identify patients likely to benefit from its drug candidates.
BiotechDigital HealthMental HealthMountain View, US
Amit Etkin(Founder)inAdam Savitz(Executive Officer)Nicholas C. Smith(Executive Officer)Michael Hanley(Executive Officer)Aaron Weaver(Director)Po Yu (Jeff) Chen(Director)
Co-investorsAble PartnersAlpha Wave GlobalInVivium CapitalK2 HealthVenturesKorify CapitalVivo Capital+3 more
Dallas, US
Thomas J. Schaefer(Executive Officer, Director)Matthew T Plavan(Executive Officer)Rajendra Ketkar(Executive Officer, Director)inEric J. Rey(Executive Officer, Director)inMark Wong(Director)James Reis(Director)
Arvinas is a biopharmaceutical company developing PROTAC protein degrader therapies, with a pipeline focused on oncology and neurology.
BiotechHealthtechNew Haven, US
Sean Cassidy(Executive Officer)inManuel Litchman(Executive Officer, Director)in
BoardStephen Squinto(Director)inLiam Ratcliffe(Director)inTim Shannon(Director)inKush Parmar(Director)
Co-investors5AM VenturesAccess BiotechnologyCanaan PartnersConnecticut InnovationsNextech InvestRA Capital+2 more
Azitra is a clinical-stage biopharmaceutical company developing genetically engineered bacteria and proteins for treating skin diseases through precision dermatology.
AI & Machine LearningBiotechHealthtechFarmington, US
Azim Munivar(Executive Officer, Director, Promoter)
BoardStella Robertson(Director)inTravis Whitfill(Executive Officer, Director, Promoter)in
Co-investorsBios PartnersKdT Ventures
Beta Bionics develops the iLet Bionic Pancreas System, an insulin delivery device for people with type 1 diabetes aged 6 and older that requires a physician's prescription.
Digital HealthHealthtechMedical DevicesIrvine, US
Edward Damiano(Executive Officer, Director)Gilbert Clarke(Executive Officer)Edward Raskin(Executive Officer, Director)Mike Roskino(Executive Officer)Agustin Mohedas(Director)Jeff Hitchcock(Director)
Co-investorsOmega Funds
BillionToOne is a precision diagnostics company that uses molecular counting technology to develop non-invasive prenatal screening and liquid biopsy tests for early disease detection.
BiotechDigital HealthHealthtechMedical DevicesSan Francisco, US
Oguzhan Atay, PhD(Co-Founder, CEO, and Board Chair)David Tsao, PhD(Co-Founder, CTO, and Board Member)Oguzhan Atay(Founder)inDavid Tsao(Founder/CTO)inSukrit Silas(Cofounder)in
Co-investors500 Emerging Europe500 GlobalAsymmetry VenturesCivilization Ventures Management, Llce2vcFifty Years+16 more
BiotechMelville, US
Mark Weinreb(Chief Executive Officer, Chairman of the Board and President)Robert Kristal(Executive Officer)Francisco Silva(Director, Executive Officer)Lance Alstodt(Director, Executive Officer)Edward L. Field(President, Disc/Spine Division)Mandy Clyde(Vice President of Operations and Secretary)
Cartesian Therapeutics is a clinical-stage biotechnology company developing mRNA-based cell therapies aimed at treating autoimmune diseases.
BiotechHealthtechWatertown, US
Metin Kurtoglu(Executive Officer)Omid Farokhzad(Director)Chris Jewell(Executive Officer)inCarsten Brunn(President, CEO & Chairman of the Board)inEmily English(Executive Officer)inBlaine Davis(Executive Officer)in
Co-investorsK2 HealthVenturesMaryland TEDCOSchooner CapitalTEDCOPolaris Partners
CEL-SCI Corporation is a biotech company developing immunotherapies, particularly Multikine, which is advancing through FDA regulatory processes.
BiotechHealthtechMedical DevicesVienna, US
Patricia B. Prichep(Executive Officer)Eyal Talor(Executive Officer)inGeert R. Kersten(Chief Executive Officer)Daniel H. Zimmerman(Executive Officer)inJohn Cipriano(Executive Officer)
BoardPeter Young(Director)
Cellectar Biosciences is a clinical-stage oncology company developing targeted cancer therapies using its proprietary PLE (phospholipid ether) delivery platform, which delivers therapeutic payloads directly to cancer cells.
BiotechHealthtechMadison, US
Jamey P. Weichert(Executive Officer, Director)inJohn E. Friend II(Executive Officer)James V. Caruso(Executive Officer, Director)Jarrod Longcor(Executive Officer)inSimon Pedder(Executive Officer, Director)inChad J. Kolean(Executive Officer)in
Co-investorsVenture Investors Health Limited Partnership
Champions Oncology offers a KRAS-focused preclinical platform built on patient-derived xenograft (PDX) models screened with the pan-RAS(ON) inhibitor daraxonrasib, combining in vivo pharmacology with multi-omic characterization to study drug response and resistance.
AI & Machine LearningBiotechHealthtechHackensack, US
Ronnie Morris(Executive Officer, Director)inRonnie Morris, M.D.(Executive Officer, Director)inJames McGorry(Executive Officer)David Miller(Chief Financial Officer)inJoel Ackerman(Executive Officer, Director)inRob Brainin(Chief Executive Officer)in
Co-investorsBattery VenturesNew Enterprise Associates (NEA)Israel Biotech Fund
Collegium Pharmaceutical is a biopharmaceutical company developing a portfolio of medications to treat serious medical conditions.
BiotechCanton, US
Michael Heffernan(Executive Officer, Director)inPaul Brannelly(Executive Officer)in
BoardEran Nadav(Director)John Freund(Director)Patrick Heron(Director)inDavid Hirsch(Director)
Co-investorsAPERTURE Venture PartnersEcoR1 CapitalFrazier Life SciencesLongitude Capital
Context Therapeutics develops clinical-stage T cell engaging bispecific antibody therapies for the treatment of solid tumors.
BiotechHealthtechPhiladelphia, US
Martin Lehr(Founder)inJennifer Minai-Azary(Executive Officer)inAlex Levit(Executive Officer)Linda Beth West(Director)Richard Jay Berman(Director)Philip Kantoff(Director)
Co-investorsNextech InvestTorrey Pines Investment
Editas Medicine develops gene editing medicines using CRISPR/Cas9 and CRISPR/Cas12a technology to treat serious diseases including blood disorders, cardiovascular conditions, and cancer.
BiotechDeep TechMedical DevicesCambridge, US
Feng Zhang(Scientific Founder, Core Member, Broad Institute of MIT and Harvard)George Church(Scientific Founder, Professor of Genetics, Harvard University and MIT)inKeith Joung(Scientific Founder, Professor of Pathology, Harvard Medical School)inDavid Liu(Scientific Founder, Professor of Chemistry and Chemical Biology, Harvard University)inKatrine Bosley(Executive Officer, Director)inVic Myer(Executive Officer)in
Co-investorsEcoR1 CapitalSofinnova Ventures
FibroBiologics develops fibroblast cell-based therapies for chronic and degenerative conditions, targeting areas such as multiple sclerosis and other autoimmune diseases, degenerative disc disease, wound healing, and age-related organ decline (thymus and spleen).
BiotechHealthtechLongevityHouston, US
Pete O'Heeron(Chairman, Founder and Chief Executive Officer)inJason D. Davis(Chief Financial Officer)in
BoardStacy Coen(Director)Matthew Link(Director)Robert Hoffman(Director)Victoria Niklas(Director)
Ginkgo Bioworks builds autonomous labs and offers cell-programming and bioengineering services for the biopharma, agriculture, and industrial biotech markets.
AgTechAI & Machine LearningBiotechDeep TechHealthtechBoston, US
Jason Kelly(Founder)inAustin Che(Founder)inTom Knight(Founder)inBarry Canton(Founder)inReshma Shetty(Founder)in
BoardReshma Sohoni
Co-investors11.2 CapitalB3 HoldingCannage CapitalCool Climate CollectiveDCVC (Data Collective)Designer Fund+19 more
INmune Bio is a clinical-stage biotechnology company developing immunotherapies, including XPro1595, aimed at treating neurodegenerative and psychiatric diseases through a biomarker-directed approach.
BiotechDigital HealthHealthtechLa Jolla, US
Mark Lowdell(CSO/CMO)Raymond Tesi(Chief Executive Officer)David J. Moss(CEO)inJ. Kelly Ganjei(Director)Terry R. Knapp(Director)
HealthtechJupiter, US
Jacob Uittenbogaard(Chief Financial Officer, Treasurer and Secretary)Marshall Hayward(Chief Scientific Officer)Christer Rosen(Chief Executive Officer and President)
BiotechArlington, US
Justin Hanes(Director)Kevin Pojasek(Executive Officer)Darius Kharabi(Executive Officer)Todd Bazemore(Executive Officer)Mark Iwicki(Executive Officer, Director)Mary Reumuth(Executive Officer)
Co-investorsLongitude CapitalSR One Capital ManagementYsios CapitalAtlas VentureLux CapitalThird Rock Ventures
Marker Therapeutics develops novel T cell therapies, including adoptive T cell therapy approaches, for clinical applications in oncology and other diseases with high unmet need.
BiotechHealthtechHouston, US
Juan Vera(Executive Officer, Director)inDr. Vera(Co-founder)Glynn Wilson(Executive Officer, Director)John Bonfiglio(Executive Officer, Director)
BoardSteven Elms(Director)inJohn Wilson(Director)
Co-investorsAisling CapitalNew Enterprise Associates (NEA)
Mobia Medical (formerly MicroTransponder) develops Vivistim Paired VNS Therapy, an FDA-approved treatment for stroke survivors with moderate to severe upper extremity impairment.
Digital HealthHealthtechMedical DevicesAustin, US
Richard John Foust(Executive Officer, Director)Frank McEachern(Executive Officer, Director)in
BoardNelson Bunker Curnes(Executive Officer, Director)Thomas Jordan Curnes II(Executive Officer, Director)Casey Tansey(Director)Dana Mead(Director)
Co-investorsLongitude CapitalUT Horizon FundGreen Park & Golf VenturesUS Venture Partners
Myomo develops wearable robotic orthoses to restore arm and hand function for individuals with limited mobility due to stroke, brachial plexus injury, or spinal cord injury.
HardwareHealthtechMedical DevicesRoboticsCambridge, US
Paul R. Gudonis(Chairman & Chief Executive Officer)inSteve Kelly(Executive Officer, Director)
BoardThomas Kirk(Director)Byron Smith(Director)Thomas A. Crowley, Jr.(Director)
Co-investorsBoston Harbor Angels
Omada Health provides virtual-first, integrated care programs for chronic disease management, delivered as data-driven solutions for employers, health plans, and healthcare organizations.
Digital HealthHealthtechWellness & FitnessSan Francisco, US
Andrew DiMichelle(Executive Officer, Director)Adrian James(Executive Officer, Director)inSean Duffy(Executive Officer, Director)inWei-Li Shaoin
BoardJonathan Root(Director)inCasper De Clercq(Director)in
Co-investorsAndreessen HorowitzBlackbird GiantsCanvas VenturesCivilization Ventures Management, LlcDesigner FundFounder Collective+13 more
Oragenics develops treatments for concussion and traumatic brain injury, focusing on clinical development of therapeutic candidates.
BiotechDeep TechDigital HealthLongevityMedical DevicesTampa, US
Alan Joslyn(Executive Officer, Director)inMichael Sullivan(Executive Officer)Janet Huffman(Chief Executive Officer & Chief Financial Officer)James P. Kelly(Chief Medical Officer)William Peacock(Chief Clinical Officer)
BoardRobert Koski(Director)
PDS Biotech develops T cell activating immunotherapies for cancer and infectious disease vaccines in clinical stages.
BiotechHealthtech
Co-investorsElevate Ventures
Protagonist is a company that emphasizes a diverse and inclusive corporate culture as central to its innovation, with stated goals of creating wins for its organization and for patients.
BiotechHealthtechMilpitas, US
Dinesh V. Patel, PhD(Executive Officer, Director)Dinesh Patel(President & Chief Executive Officer)
BoardAsish K. Xavier, Ph.D.(Director)Michael Panaccio, Ph.D.(Director)Armen Shanafelt, Ph.D.(Director)Paul F. Truex(Director)
Co-investorsAisling CapitalCanaan PartnersJJDCLilly VenturesStarfish Ventures
BiotechMiami Beach, US
Eddie Sullivan(Executive Officer, Director)inEddie J Sullivan(Founder)inSamuel Reich(Executive Officer, Director)inRussell Beyer(Executive Officer)in
BoardJeffrey Spragens(Director)Andrew Moin(Director)
Savara is a biopharmaceutical company developing treatments for autoimmune pulmonary alveolar proteinosis (autoimmune PAP) and other rare lung diseases.
BiotechHealthtechMedical DevicesAustin, US
Matt Pauls(Chair of the Board of Directors and Chief Executive Officer)inMike Ciesla(Executive Officer)Badrul Chowdhury(Executive Officer)inSantosh J. Vetticaden(Executive Officer)Gregory D. Gorgas(Executive Officer)Patrick Keran(Executive Officer)
Co-investorsBain Capital Life SciencesCentral Texas Angel NetworkGreen Park & Golf VenturesKeiretsu ForumMoore Venture PartnersNew Enterprise Associates (NEA)
SCYNEXIS develops fungerp-based antifungal therapies, including SCY-247, for treating and preventing severe, progressive, and often fatal fungal diseases and antimicrobial-resistant infections.
BiotechDurham, US
Yves J. Ribeill(Executive Officer, Director)inCharles F. Osborne, Jr.(Executive Officer)Brian Schwab(Executive Officer)in
BoardLaurent Arthaud(Director)Mounia Chaoui(Director)Jean-Yves Nothias(Director)
Co-investorsDecheng CapitalForesite Capital
Seer develops proteomics tools for large-scale protein analysis, including an assay, automation instrument, and analysis software for studying the proteome across human and non-human samples.
BiotechDeep TechHardwareHealthtech
Omid Farokhzad(Chair and Chief Executive Officer)in
Co-investorsSoftBank Vision FundSolasta VenturesWingaMoonMaverick Ventures
Senti Bio develops cell and gene therapies for cancer and difficult-to-treat diseases using synthetic biology and engineered Gene Circuits to enhance precision, control, and selectivity in targeting tumor cells.
BiotechDeep TechMedical DevicesSouth San Francisco, US
Tim Lu(Co-Founder and Chief Executive Officer)inPhilip Lee(Executive Officer)inKanya Rajangam(President, Head of Research & Development and Chief Medical Officer)inYvonne Li(Executive Officer)inJames Collins(Director)
BoardDonald Tang(Director)
Co-investorsEvolution VC PartnersFlucas VenturesLifeforce CapitalLux CapitalMenlo VenturesNew Enterprise Associates (NEA)+3 more
BiotechPrinceton, US
Richard C. Straube, MD MSc(Executive Officer)Karen Krumeich(Executive Officer)Oreola Donini, PhD(Executive Officer)Christopher J. Schaber, PhD(Executive Officer, Director)Adam T. Rumage(Executive Officer)R. Christopher Cavalli, PhD(Executive Officer)
Co-investorsPontifax Venture Capital
Emmune develops synthetic antibodies for HIV treatment and prevention, using engineered proteins that block viral infection pathways.
BiotechDeep TechDigital HealthHealthtechMedical DevicesMiami, US
Dr. Alpert(President & Co-founder)Dr. Michael FarzanDr. Charles BaileyDr. Matthew GardnerDr. Guocai Zhong
InformAI develops AI-guided clinical solutions for oncology and diagnostic imaging to improve patient treatment outcomes.
AI & Machine LearningDigital HealthHealthtechMedical DevicesHouston, US
Co-investorsJoyance PartnersSocial StartsDEFTA Partners
STRM.BIO develops technology to deliver gene therapies, aiming to improve how these treatments reach patients.
BiotechDeep TechHealthtechLongevityMedical Devices
Michael Luther(CEO)in
Co-investorsAscension VenturesBreakout LabsBreakout VenturesDelos CapitalNYBC VenturesKdT Ventures
149 Bio develops integrin-targeted therapies for kidney disease, with a lead program (ONT01) that is a Phase 1/2-stage small molecule integrin αMβ2 (CD11b) agonist for lupus nephritis and focal segmental glomerulosclerosis.
AI & Machine LearningBiotechDeep Tech
1910 Genetics develops genetic engineering and biotechnology solutions, leveraging computational and biological approaches.
AI & Machine LearningBiotechDeep TechCambridge, US
Jennifer O. Nwankwo(Executive Officer, Director)
BoardSamir Kumar(Director)Marc Foster(Director)Jory Bell(Director)in
Co-investorsFoundersX VenturesPlayground GlobalY CombinatorEmles Venture PartnersM12 (Microsoft's Venture Fund)Accenture Ventures
20/20 BioLabs develops laboratory blood tests using machine learning for the early detection of cancers and chronic diseases, including a multi-cancer early detection (MCED) protein tumor marker test and an inflammation biomarker test.
AI & Machine LearningBiotechDigital HealthGaithersburg, US
Jonathan Cohen(Executive Officer, Director)inMr. Cohen(Founder, CEO & President)Anne Shiflett(Executive Officer)Jiminy Zhou(Executive Officer)Dr. Lebowitz(Chief Scientific Officer)Mr. Bergman(Chief Financial Officer)
Co-investorsKeiretsu Forum
21CM develops advanced biopreservation technologies, including vitrification and cryopreservation solutions, for preserving living systems ranging from mammalian cells to whole organs in biomedical research and clinical applications.
BiotechDeep TechFemTechHealthtechLongevityMedical DevicesFontana, US
Greg Fahy(Chief Scientific Officer)
2Morrow provides evidence-based digital wellness programs delivered through a smartphone and web app, using Acceptance and Commitment Therapy principles to help people quit tobacco, manage stress, and change health behaviors.
Digital HealthMental HealthWellness & FitnessKirkland, US
Jo Masterson(Executive Officer, Director)inBrandon Masterson(Executive Officer)in
BoardJohn Koster(Director)Eric Larsen(Director)
Co-investorsPortland Seed FundWRF Capital
3D Molecular Designs operates SMART Teams, an educational program where students model protein structures using molecular visualization tools and 3D printing to communicate research findings.
BiotechDeep TechEdTechHealthtechMilwaukee, US
Tim Herman(Founder & PhD)Diane Herman(Co-founder & Business Manager)
3Helix develops and sells collagen hybridizing peptides (CHP) and related conjugates for research and diagnostic applications.
BiotechHealthtechMedical DevicesNew MaterialsSalt Lake City, US
Mike Kirkness(CEO)Toby Barrack(VP)Michael Fugman(Director)Michael Yu(Director)Noah Nasser(Director)
Co-investorsUtah Innovation Fund
3P Biotechnologies identifies plant-derived bioactive compounds and develops drug delivery systems targeting cancer and chronic disease prevention.
BiotechDeep TechHealthtechLouisville, US
Dr. Gupta(Founder)Al Poskanzer, PhD(Director of Strategic Partnerships)Niti Gupta, BA(Director of Finances & Administration)
San Francisco, US
Todd Huffman(Executive Officer, Director)Megan Klimen(Executive Officer)
BoardJoshua Wolfe(Director)Matt Ocko(Director)Adam Goulburn(Director)inAdam Goulborn(Director)
Co-investorsComet LabsDimension Capital
490 BioTech develops autobioluminescent assay technology that enables cells to produce light autonomously without external luciferin or excitation, allowing continuous, non-destructive monitoring of cellular viability and metabolic activity.
BiotechDeep TechMedical Devices
BiotechAustin, US
Joseph Price(Director)Eric Price(Director)Thomas Craig Benson(Executive Officer, Director)Theodore Price(Director)
Aavogen is a biotechnology company focused on muscle disease treatment through gene therapy.
BiotechDeep TechHealthtechMedical Devices
Buel Dan Rodgers(Founder & CEO)Chris Novashinski(Co-Founder & COO)Gary Carswell(Founder & President)
Abalone Bio develops target-activating antibodies for difficult-to-drug disease targets by combining engineered biology with machine learning.
AI & Machine LearningBiotechDeep TechHealthtechSan Francisco, US
Richard Yu(Founder)inGustavo Pesce(Founder)in
Co-investorsHorizons VenturesMetaplanetY CombinatorBoxOne Ventures
AbbraTech develops a platform technology for the discovery, engineering, and validation of antibodies, targeting disease-relevant proteins that are difficult to address with conventional approaches.
BiotechDeep TechBranford, US
Michael Weiner(Founder)in
Co-investorsConnecticut Innovations
Abilita Therapeutics is a drug discovery company built on its EMP (Enabled Membrane Proteins) technology, which uses directed evolution to create stability- and expression-enhanced membrane protein variants.
BiotechDeep Tech
Co-investorsTwo Bear Capital
HealthtechSt. Paul, US
Angeline Conley(Executive Officer, Director)Aaron Fletcher(Director)Donald Santel(Director)Steve Seme(Executive Officer)
Co-investorsDEFTA PartnersIrishAngels
AbleLink Smart Living Technologies develops research-based assistive and cognitive technologies, including GPS-guided travel apps, step-by-step daily living supports, simplified desktop software, and accessible cloud-based survey systems.
Digital HealthHealthtechImpact & Social Good
Dan Davies(Founder & President)
San Diego, US
Bradley Messmer(Executive Officer, Director)
BoardNeil Senturia(Director)
Co-investorsVertical Venture Partners
BiotechLouisville, US
Ronald Nutt(Director)Thomas E Welch(Executive Officer, Director)Robert A Vincill(Executive Officer)
BoardDennis Dougherty(Director)Bengt Langstrom(Director)
Academic Webpages is a web services company that builds and maintains websites for academic institutions.
EdTechSaaS
Nancy McNamara(Founder and President)
ACatechol develops bioinspired surface treatment technologies to prevent infections in medical devices, particularly catheters, by inhibiting biofilm formation.
BiotechHealthtechMedical DevicesNew MaterialsSanta Barbara, US
Kollbe Ando Ahn(Chief Executive Officer)Phillip Ho(EVP of Product Development)Eric Ryan(Chief Financial Officer)Jin-Soo Ahn(Executive Officer, Director)Byung-Jun Ahn(Executive Officer, Director)
BoardJinsoo Ahn(Clinical Advisor)
Healthy Dining Inc. develops digital health and wellbeing technology that helps people optimize their eating habits for health, performance, and longevity.
Digital HealthFoodTechHealthtechWellness & Fitness
Accudava develops diagnostic kits that predict patient response to platinum-based chemotherapy, helping oncologists identify which patients will benefit from standard cancer treatment.
AI & Machine LearningBiotechDigital HealthHealthtechMedical Devices
Dr. Nahid Razi(CEO, Founder)
Acoustica.bio develops acoustophoretic technology and microgel suspension formulations that concentrate biologic drugs (such as monoclonal antibodies) to ultra-high concentrations exceeding 500 mg/mL for small-volume subcutaneous injection.
BiotechDeep TechMedical Devices
Daniele Foresti(Founder)
Co-investors3CC | Third Culture CapitalSafar Partners
Acpharis develops computational drug discovery software, including computational solvent mapping to identify druggable protein binding sites and protein-protein docking tools tested in CAPRI.
AI & Machine LearningBiotechDeep Tech
Sandor Vajda, Ph.D.(Founder)Dima Kozakov, Ph.D.(Founder)Dmitri Beglov, Ph.D.(CEO)
Acrigen develops precision gene editing systems based on CRISPR, using novel αCas and μCas nuclease libraries paired with engineered anti-CRISPR (ErAcr) proteins to reduce off-target edits.
BiotechDeep TechHealthtechKensington, US
Joseph Bondy-Denomy(Director)David Rabuka(Executive Officer, Director, Promoter)Karen Boezi(Director)
Co-investorsBerkeley CatalystDolby Family Ventures
Actinium is developing targeted radiotherapy treatments using Actinium-225 and related isotopes for oncology indications including prostate cancer, non-small cell lung cancer, breast cancer, and acute myeloid leukemia.
BiotechHealthtechMedical DevicesNew York, US
Dragan Cicic(Chief Operating Officer and Chief Medical Officer)Sergio Traversa(Interim Chief Financial Officer)Kaushik J. Dave(President and Chief Executive Officer)Sandesh Seth(Chairman of the Board)
BoardDavid Nicholson(Director)Richard I. Steinhart(Director)
Activated Research Company (ARC), founded in 2014, develops chemical analysis detection technologies such as gas chromatography add-ons (Polyarc and Jetanizer) that improve data accuracy and sample throughput.
Deep TechHardwareNew Materials
BoneScore makes the OsteoProbe, a handheld, radiation-free medical device that measures bone tissue strength by delivering a controlled impact and producing a Bone Material Strength Index (BMSi).
Deep TechDigital HealthHealthtechMedical DevicesSanta Barbara, US
Paul Hansma(Co-founder)Alexander Proctor(Co-founder)Steven Dorfman(Director)Peter Burks(Executive Officer)Linda Heller(Director)Bill Casner(Director)
HealthtechCarlsbad, US
Theodore DeFrank(Chief Executive Officer and President of Issuer)Patrick Yount(Chief Financial Officer of Issuer)Stephanie Liva(Director)August Sick(Director)Mary Janatpour(Director)Tammy Brach(Director)
Actuated Medical develops a precision platform for guiding deep brain therapy delivery in patients with neurological and neurodegenerative disorders.
BiotechDeep TechHealthtechMedical DevicesBellefonte, US
Paul Frankhouser(Director)Robert Emert(Director)Maureen Mulvihill(Executive Officer, Director)
Acumen Pharmaceuticals is developing treatments for Alzheimer's disease and other neurodegenerative diseases, focusing on understanding and targeting amyloid beta oligomers in neurodegeneration.
BiotechHealthtechLongevityMedical Devices
Daniel O'ConnellJim Doherty, PhDEric Siemers, MDinMatthew ZugaRussell Barton, MSAmy Schacterle, PhD
Co-investorsK2 HealthVentures
BiotechPasadena, US
Justin Ichida(Director)inSam Alworth(Founder)inMarcel van der Brug(Executive Officer)in
BoardQing Liu-Michael(Director)Paul August(Director)
Co-investorsKeiretsu Forum
Acurex is developing CU-00048, a T-type selective calcium inhibitor in clinical development for Essential Tremor, a neurological disorder affecting millions of patients.
BiotechLongevityMedical Devices
Lev Leytes(CEO and Co-Founder, Chairman of the Board)William D. Shrader(CSO and Co-Founder)Galina Leytes(COO and Co-Founder, Director)
ADA Technologies manufactures energy storage products for specialized defense applications.
Advanced ManufacturingDeep TechDefense TechEnergyHardwareEnglewood, US
Russ Farmer(President & CEO)Nada Farmer(Vice President & Chief Financial Officer)James Dong(Vice President of Research and Development)Sayan Naha(Vice President, Business Development)
Adámas manufactures nanodiamond materials and quantum sensing instrumentation for research and applications in life sciences, biomanufacturing, and nanocomposites.
BiotechDeep TechNew MaterialsQuantum Computing
Dr. Olga Shenderova(President, CTO)Dr. Gary McGuire(Director of Business Development)
Adaptive Testing Technologies develops cloud-based assessment tools for mental health screening and diagnosis.
AI & Machine LearningDigital HealthHealthtechMental HealthSaaS
Ellen Frank(Founder)
Adecto Pharmaceuticals develops therapeutic and diagnostic products targeting cancer, with a focus on antibody-based treatments for breast cancer.
BiotechHealthtechMedical DevicesBoston, US
Nora D. Mineva(Co-founder, CEO & CSO)Gail E. Sonenshein(Co-founder & President)Mathilde Romagnoli(Co-founder & Advisor - Strategic Planning & Scientific Approach)
Adelphi Technology manufactures neutron generators using Deuterium-Tritium, Deuterium-Deuterium, and thermal neutron sources, offering both actively pumped and sealed systems with yields up to 2x10^10 n/s.
Advanced ManufacturingDeep TechHardwareMedical DevicesRedwood City, US
Melvin Piestrup(Founder/Chairman)
Adeptrix develops the exoBAMS platform, using antibody-based immunoaffinity capture of extracellular vesicles combined with MALDI mass spectrometry to profile proteins, lipids, metabolites and other molecules from a single blood sample.
AI & Machine LearningBiotechMedical Devices
Co-investorsFormation Venture Engineering
Adhera develops AI health agents that support families managing pediatric chronic conditions by providing empathic, personalized guidance and care coordination.
AI & Machine LearningDigital HealthHealthtech
Ricardo C. Berrios(Co-founder and Chief Executive Officer)Luis Fernandez-Luque(Co-founder and Chief Scientific Officer)
BiotechNew York, US
Christopher Frigon(Executive Officer)Jeffrey Gardner(Executive Officer)Tyler Martin(Executive Officer, Director)Phil Livingston(Director)
BoardMary Gin(Director)John Gallo(Director)
BiotechChicago, US
Erik B. Kulstad(President)
BoardMark Ritz(Director)Cliff Turner(Director)Don Morath(Director)Igal Ladabaum(Director)Rick McCaulley(Director)
Arcnano is a specialty contract manufacturer operating a MEMs-level thin film wafer fabrication facility and precision engineering machine shop, serving customers in defense, aerospace, semiconductor, and scientific instrument industries.
Advanced ManufacturingDeep TechDefense TechSemiconductorsWhite Bear Lake, US
Matt Dugas(Founder)Judy Oscislowski(Chief Financial Officer)
Advirna provides research tools and support for therapeutic oligonucleotide and gene knockdown studies, serving laboratories worldwide in the biotechnology field.
AI & Machine LearningBiotechDeep Tech
Dr. Alexey Wolfson(Founder)Dr. Anastasia Khvorova(Founder)Alexey Wolfson, PhD, MBA(Chief Executive Officer & Chief Scientific Officer)
Advanced Silicon Group works in nanotechnology, using the tagline "Nanotechnology for Life."
BiotechDeep TechMedical DevicesNew MaterialsSemiconductorsLowell, US
Marcie Black(CEO & Co-founder)inBill Rever(Chief Marketing and Sales Officer & Co-founder)in
BoardAlan Watson(Director)Sarah Kelly(Director)
Co-investorsTenon Ventures
Advanced Tactile Imaging develops tactile and ultrasound imaging devices for biomechanical mapping of the female pelvic floor to support diagnosis and treatment of women's health conditions.
Digital HealthFemTechHealthtechMedical Devices
Armen Sarvazyan(Co-founder)
ATS Bio produces Saporin, a plant-derived enzyme used as a control reagent for targeted immunotoxins and ligand toxins in research applications.
AI & Machine LearningBiotechDeep TechHealthtechMedical DevicesCalifornia, US
Douglas Lappi(Co-founder)Ronald Wiley(Co-founder)Denise Higgins
ATR develops specialized material handling equipment and machines for the United States Postal Service (USPS), including automated tag cancelling, tray processing, and package recovery systems used in mail sorting and distribution facilities.
Advanced ManufacturingDeep TechDefense TechHardwareLogistics & Supply ChainRoboticsBeltsville, US
EleGARD is an FDA-cleared and CE-marked patient positioning device and cardiopulmonary board that elevates a patient's head and thorax during airway management and cardiopulmonary resuscitation procedures.
HardwareHealthtechMedical DevicesSycamore, US
Adventium Labs offers the CAMET Library, a subscription-based collection of model-based engineering and analysis tools that help system engineers and architects detect flaws in complex cyber-physical systems during the requirements and design phases.
Deep TechDefense TechDeveloper Tools
Advertent Biotherapeutics is a biotechnology company developing first-in-class biologics that modulate TGF-β family growth factors to protect muscle quality and promote regeneration in neuromuscular disorders, with a particular focus on muscular dystrophies.
BiotechDeep TechHealthtech
Monique Floer(Co-Founder, President & CEO)Erik M. Martinez-Hackert(Co-Founder & CSO)
Co-investorsMichigan RiseWMU Biosciences Research & Commercialization Center
Aerosol Devices manufactures aerosol particle sampling devices using condensation growth tube technology for bioaerosol and chemical particle collection across the 5 nanometer to 10 micron size range.
BiotechDeep TechHardwareHealthtechFort Collins, US
Dr. Susanne HeringPat KeadyDr. Ping Chen(President)
BiotechCincinnati, US
Robert Shalwitz(Executive Officer)Joseph Gardner(Founder)inDuane Nash(Director)Kevin Peters(Executive Officer)Steve Pakola(Executive Officer)Ian A.W. Howes(Executive Officer)
Co-investorsCincyTechSofinnova VenturesOrbiMed
AfaSci is a biopharmaceutical company developing small molecule and peptide therapeutics for pain and neurology indications, with a lead candidate (AFA-281) that has completed Phase I trials for chronic pain and epilepsy.
BiotechDeep TechHardwareHealthtechSan Francisco, US
Affect Therapeutics operates an app-based digital treatment provider offering care for substance use disorders (alcohol, cannabis, opioid) and mental health conditions like depression and anxiety, using methods such as contingency management, CBT, medication-assisted treatment, and peer support.
Digital HealthHealthtechMental HealthNew York, US
Jeff DeFlavio(Co-founder)inKristin Muhlner(Executive Officer, Director)in
BoardKevin Ryan(Director)Jeff Rinehart(Director)in
Co-investorsArtis VenturesCity LightAlleyCorpLifeArc VenturesSamsung NextWhat If Ventures+1 more
Contract research organization specializing in CNS preclinical efficacy and neurotoxicity evaluations using its patented Enhanced Spine Profiling (ESP) technology.
Co-investorsTorrey Pines Investment
BiotechAlameda, US
Michael D. West(President and CEO)Russell Skibsted(Chief Financial Officer)
BoardAlfred Kingsley(Chairman)Michael H. Mulroy(Director)
Co-investorsBroadview Ventures
HealthtechNashville, US
Scott Werntz(Executive Officer, Director)Gary Slagle(Executive Officer, Director)
BoardDirector Ghertner(Director)Vic Gatto(Director)
AgileMD operates a forum for users and customers to exchange ideas, questions, and techniques related to the company's services and operations.
AI & Machine LearningDigital HealthHealthtechSaaSSan Francisco, US
Borna Safabakhsh(Founder/CEO)in
Co-investorsMDT VenturesY Combinator
BiotechAlbuquerque, US
Federica Pericle(Executive Officer, Director)Joseph Patti(Executive Officer, Director)Ebetuel Pallares(Executive Officer, Director)Faith Charles(Director)Debora E Ramirez(Executive Officer)
BoardWaneta Tuttle(Director)in
Co-investorsTramway Venture Partners
HealthtechSaint Paul, US
Morgan E. Evans(Executive Officer, Director)Morgan Clyburn(Executive Officer, Director)Robert A. Kukuljan(Executive Officer)
BoardKathleen Tune(Director)Micah Eimer(Director)Mark Pacyna(Director)
Co-investorsGROOVE CAPITALEngage Venture Partners
Aidar (Aidar Health) develops digital medicine solutions that combine physical and digital biomarkers with predictive algorithms to support precision medicine and remote patient monitoring.
AI & Machine LearningDigital HealthMedical Devices
Sathya Elumalai(Founder)in
Co-investorsMaryland TEDCOTEDCO
AIQ Solutions develops intellectual property and technologies to improve clinical treatment outcomes for patients with complex diseases globally.
AI & Machine LearningHealthtechMedical DevicesNew York, US
T. Gary Liberman(Chief Financial Officer and Secretary)Nicholas W. Stuller(Chief Executive Officer)
BoardWilliam O'Conor(Member of the Board of Directors)
Co-investorsAurora ForgeCapital Midwest FundNew York AngelsRock River Capital PartnersTundra AngelsVenture Management
Pittsburgh, US
Illah Nourbakhsh(Executive Officer, Director, Promoter)
A bioengineering and drug delivery company led by founders with expertise in neuroscience and bioengineering, bringing together experience across multiple successful startups and clinical drug developments.
BiotechDeep TechHealthtechMedical Devices
Aman Mann(Co-Founder & CEO)Erkki Ruoslahti(Co-Founder & Executive Chairman)Sazid Hussain(Co-Founder & Chief Scientific Officer)
Akelos Inc. is a clinical-stage biopharmaceutical company developing non-opioid, non-addictive drugs for chronic and neuropathic pain, based on HCN1 inhibitor compounds licensed from Weill Cornell research.
BiotechMedical DevicesNew York, US
Peter Goldstein(Scientific Co-founder)Steven Fox(Chairman)
BiotechFredrick, US
Charles Daitch(Executive Officer, Director)Jon Davis(Executive Officer)inGeorge Rudy(Executive Officer)Jennifer Reynolds(Executive Officer)inDarrell Chandler(Executive Officer)
BoardTom McMahon(Director)
BiotechHealthtechMedical DevicesBillerica, US
Brian McKelligon(Executive Officer)Garry Nolan(Director)Matthew Winkler(Director)
BoardRob Hart(Executive Officer)inRobert Shepler(Director)inThomas Raffin(Director)in
Co-investorsaMoonTelegraph Hill Partners
Akrivis manufactures modular, mission-critical air cooling and cleaning solutions for buildings and cabins, developed and fabricated at parent company Aubren's advanced manufacturing facility in Ireland.
CleantechConstruction TechEnterprise SoftwareHardwareHealthtechIreland, IE
Akston Biosciences develops protein-based therapies for pets to support veterinary care and improve treatment accessibility.
BiotechHealthtechBeverly, US
Todd C. Zion(Executive Officer, Director)inJames Herriman(Executive Officer)Robyn Davis(Director)Lovick E. Cannon(Director)Thomas M. Lancaster(Executive Officer, Director)
Co-investorsBoston Harbor AngelsFormation Venture Engineering
ALA Scientific develops BrainDancer, a dynamic phantom system that uses deep learning to identify and remove scanner-induced noise from fMRI signals, improving signal-to-noise ratios and enabling standardization across imaging sites.
AI & Machine LearningDeep TechHardwareHealthtechMedical Devices
Alamar Biosciences develops NULISA, an ultra-high-sensitivity, high-specificity technology for analyzing hundreds of protein biomarkers from small biofluid samples, building on the team's prior spatial genomics work (RNAscope).
BiotechDeep TechHealthtechFremont, US
Yuling Luo(Co-founder, CEO and Chair)Steve Chen(Co-founder, COO and Director)Yiyuan Yin(Co-founder, VP of Technology)inTod White(President)inJustin McAnear(CFO)inXiao-Jun Ma(CTO)
Co-investorsIllumina VenturesQiming Venture PartnersSamsara BioCapital
Alcamena Bio develops an AI-guided peptide discovery platform that combines computational design with high-throughput experimental screening to engineer therapeutic peptides, including those capable of crossing the blood-brain barrier for CNS targets.
AI & Machine LearningBiotechDeep Tech
Co-investorsID VenturesInvest Michigan
Aldatu Biosciences develops diagnostic tests for detecting pathogenic drug resistance, particularly HIV and other infectious diseases, using its PANDAA technology platform.
BiotechDigital HealthHealthtechMedical DevicesCambridge, US
Iain J. Macleod(Co-founder & CEO, Chief Science Officer)Marta Fernández Suárez(Co-founder, CEO and CSO)Raúl Rodriguez(Founder & Partner)Mark Urdea(Founder & Partner)David M. Raiser(Executive Officer, Director)Mike(CBO)
Alessa Therapeutics develops a proprietary drug-delivery platform for sustained and localized release of therapies to treat early-stage prostate cancer.
BiotechHealthtechMedical DevicesSan Carlos, US
Pamela Munster(Founder, Chief Scientific Advisor and Director)inCam Gallagher(Executive Officer, Director)inJohn Maroney(Executive Officer, Director)in
BoardZachary Collins(Executive Officer)inSteve Tregay(Director)inAnnie Mitsak(Director)in
Co-investorsCure VenturesMission Bay CapitalMission Biocapital
Algomedix develops non-opioid pain management therapies based on TRPA1 drug development, targeting chronic pain indications through a clinical-stage biotechnology approach.
BiotechHealthtechMedical Devices
Dr. Jeffrey Herz, Ph.D.(Founder and CEO)Jeffrey Herz(Founder, Chairman of the Board, President and Chief Executive Officer)
Alida Biosciences develops tools for RNA modification detection and analysis that enable research and diagnostic applications across drug discovery, clinical testing, and biotechnology.
AI & Machine LearningBiotechData & InfrastructureDeep TechHealthtechSan Diego, US
Byron Purse(Co-Founder)inJohn Drewry(Director)Gudrun Stengel(CEO & Co-Founder)
Co-investorsFusionX VenturesGENERAL INCEPTIONVertical Venture Partners
AllCells supplies cryopreserved human blood and bone marrow-derived cell products to research organizations worldwide, with a focus on maintaining product integrity through cold chain logistics and validated shipping protocols.
BiotechHealthtechLogistics & Supply ChainMedical DevicesBoston; San Francisco, US
Allerdia develops a rapid immunosensor-based allergy diagnostic test using its patented Reverse-Lateral Flow ImmunoAssay (R-LFIA) platform, which detects allergic IgE from a small drop of serum or capillary blood within 15 minutes at the point of care.
BiotechDigital HealthMedical DevicesTorrance, US
Allergyamulet develops a portable food allergen and ingredient sensor to help people with food allergies safely identify potential allergens in food before consumption.
ConsumerHardwareHealthtechMedical Devices
Abigail Barnes(Co-Founder & CEO)in
Co-investorsAllerfund Ventures, LlcColle Capital PartnersDipalo VenturesGreat North VenturesGreat Oaks Venture CapitalHealthX Ventures+2 more
Alleviant Medical develops an investigational minimally invasive medical device using interatrial shunt therapy to treat heart failure patients, currently in FDA-approved clinical trials (ALLAY-HF and ALLAY-HFrEF).
BiotechHealthtechMedical DevicesAustin, US
Adam Berman(Executive Officer, Director)inJacob Kriegel(Executive Officer, Director)Avni Patel(Executive Officer, Director)Christopher Alex Arevalos(Executive Officer, Director)Albertien Greijdanus(Executive Officer, Director)
BoardGeoff Pardo(Director)
Co-investorsBroadview VenturesRiverVest Venture PartnersTMC Venture FundCadence Healthcare VenturesGilde HealthcareGilmartin Capital LLC+2 more
Allyx Therapeutics is a clinical-stage biopharmaceutical company developing therapies to preserve and protect synapses in people with neurodegenerative diseases.
BiotechDigital HealthHealthtechNew Haven, US
Paul Fonteyne(Co-Founder)Stephen Strittmatter(Scientific Founder)Stephen Bloch(CEO, Co-Founder)inTimothy Siegert(COO, Co-Founder)inJennifer Gabler(Executive Officer)in
BoardRobert A. Bettigole(Director)in
Co-investorsElm Street VenturesSpring Mountain CapitalConnecticut InnovationsWHIN
Alpenglow Biosciences offers a 3D spatial biology platform (Aurora 3D) that uses open-top light-sheet microscopy and AI analysis to turn intact tissue into quantitative volumetric data.
AI & Machine LearningBiotechMedical DevicesSeattle, US
Co-investorsAvant Bio
Alpha Young is a biotech company founded in 2019 that conducts research and develops medical treatments focused on chronic kidney disease, aging, and related conditions.
BiotechHealthtechLongevity
Altay Therapeutics develops small molecule inhibitors targeting transcription factors to treat serious diseases including facioscapulohumeral muscular dystrophy and cancer.
BiotechDigital HealthHealthtechMedical DevicesSan Francisco, US
Ali Ozes(Founder)inOsman Ozes(Founder)in
Co-investorsCreative Destruction Lab (CDL)Tachyon VenturesY Combinator
Altis Biosystems builds RepliGut®, human intestinal tissue models grown from human intestinal stem cells that provide human-relevant preclinical data for drug absorption, metabolism, toxicity, and disease modeling.
BiotechDeep TechHealthtechMedical DevicesDurham, US
Christopher Sims(Executive Officer)inJimmy Smedley(Executive Officer)inSamuel Franklin(Director)Joseph McMahon(Director)Michael Biron(Executive Officer, Director)
BoardChristopher Perkins(Director)
Co-investorsAtlanta Technology AngelsCentral Texas Angel NetworkCheckmate Capital Group LLCIDEA NCJohnson Venture PartnersVentureSouth+1 more
BiotechLa Jolla, US
Quyen Nguyen(Executive Officer, Director)inKaveri Parker(Executive Officer)inBrett Berman(Executive Officer, Director)inJames Schmidt(Executive Officer)in
BoardKim Kamdar(Director)Dan Bradbury(Director)in
Co-investorsBioBrit
Co-investors+ND CapitalSanofi VenturesSolasta Ventures
Alva Health develops wearable medical devices that continuously monitor for early signs of stroke and alert emergency responders in real time.
AI & Machine LearningDeep TechHealthtechIoTMedical DevicesWellness & FitnessDallas, US
Sandra Saldana(Executive Officer, Director)
Co-investorsTechstars
Co-investorsCentral Texas Angel NetworkDolby Family Ventures
BiotechLaguna Hills, US
George Guikai Wu(Executive Officer, Director)Yonglei Shang(Executive Officer, Director)Weian Zhao(Director)
Ambigroup provides waste management, demolition, and dismantling services with a focus on construction and demolition waste (RCD), operating recycling facilities that turn waste and materials into secondary raw materials.
Circular EconomyCleantechConstruction Tech
BiotechLa Jolla, US
Gregory Hook(Co-Founder, Vice President Research and Corporate Counsel)Michael D. Pierschbacher(President and Chief Executive Officer)
BoardBernice Welles(Director)J. Gregory Swendsen(Director)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.